0

Journal Articles

in Acute Coronary Syndrome
 21-40 of 65 Articles
Original Contribution |  May 02, 2007 FREE
Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006
Keith A. A. Fox, MB, ChB, FRCP; Philippe Gabriel Steg, MD; Kim A. Eagle, MD; et al.
JAMA. 2007;297(17):1892-1900. doi:10.1001/jama.297.17.1892.
Editorial |  April 25, 2007
Does Ranolazine Have a Place in the Treatment of Acute Coronary Syndromes?
L. Kristin Newby, MD, MHS; Eric D. Peterson, MD, MPH
JAMA. 2007;297(16):1823-1825. doi:10.1001/jama.297.16.1823.
Original Contribution |  April 25, 2007 FREE
Effects of Ranolazine on Recurrent Cardiovascular Events in Patients With Non–ST-Elevation Acute Coronary Syndromes:  The MERLIN-TIMI 36 Randomized Trial
David A. Morrow, MD, MPH; Benjamin M. Scirica, MD, MPH; Ewa Karwatowska-Prokopczuk, MD; et al.
JAMA. 2007;297(16):1775-1783. doi:10.1001/jama.297.16.1775.
Original Contribution |  April 11, 2007 FREE
Nonvalidation of Reported Genetic Risk Factors for Acute Coronary Syndrome in a Large-Scale Replication Study
Thomas M. Morgan, MD; Harlan M. Krumholz, MD, MS; Richard P. Lifton, MD, PhD; et al.
JAMA. 2007;297(14):1551-1561. doi:10.1001/jama.297.14.1551.
Editorial |  February 14, 2007
Optimal Timing for Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes:  Questions, Answers, and More Questions
Kenneth W. Mahaffey, MD; Robert A. Harrington, MD
JAMA. 2007;297(6):636-639. doi:10.1001/jama.297.6.636.
Original Contribution |  February 14, 2007 FREE
Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes:  The ACUITY Timing Trial
Gregg W. Stone, MD; Michel E. Bertrand, MD; Jeffrey W. Moses, MD; et al.
JAMA. 2007;297(6):591-602. doi:10.1001/jama.297.6.591.
Review |  May 03, 2006 FREE
Effects of Early Treatment With Statins on Short-term Clinical Outcomes in Acute Coronary Syndromes:  A Meta-analysis of Randomized Controlled Trials
Matthias Briel, MD; Gregory G. Schwartz, MD, PhD; Peter L. Thompson, MD, FRACP; et al.
JAMA. 2006;295(17):2046-2056. doi:10.1001/jama.295.17.2046.
Original Contribution |  April 26, 2006 FREE
Association Between Hospital Process Performance and Outcomes Among Patients With Acute Coronary Syndromes
Eric D. Peterson, MD, MPH; Matthew T. Roe, MD, MHS; Jyotsna Mulgund, MS; et al.
JAMA. 2006;295(16):1912-1920. doi:10.1001/jama.295.16.1912.
Original Contribution |  April 05, 2006 FREE
Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment:  The ISAR-REACT 2 Randomized Trial
Adnan Kastrati, MD; Julinda Mehilli, MD; Franz-Josef Neumann, MD; et al.
JAMA. 2006;295(13):1531-1538. doi:10.1001/jama.295.13.joc60034.
Original Contribution |  December 28, 2005 FREE
Excess Dosing of Antiplatelet and Antithrombin Agents in the Treatment of Non–ST-Segment Elevation Acute Coronary Syndromes
Karen P. Alexander, MD; Anita Y. Chen, MS; Matthew T. Roe, MD, MHS; et al.
JAMA. 2005;294(24):3108-3116. doi:10.1001/jama.294.24.3108.
Original Contribution |  November 23, 2005 FREE
High-Risk Patients With Acute Coronary Syndromes Treated With Low-Molecular-Weight or Unfractionated Heparin:  Outcomes at 6 Months and 1 Year in the SYNERGY Trial
Kenneth W. Mahaffey, MD; Marc Cohen, MD; Jyotsna Garg, MS; et al.
JAMA. 2005;294(20):2594-2600. doi:10.1001/jama.294.20.2594.
Original Contribution |  September 28, 2005 FREE
β2-Adrenergic Receptor Genotype and Survival Among Patients Receiving β-Blocker Therapy After an Acute Coronary Syndrome
David E. Lanfear, MD; Philip G. Jones, MS; Sharon Marsh, PhD; et al.
JAMA. 2005;294(12):1526-1533. doi:10.1001/jama.294.12.1526.
Review |  June 15, 2005 FREE
Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes:  A Collaborative Meta-analysis of Randomized Trials
Shamir R. Mehta, MD, MSc; Christopher P. Cannon, MD; Keith A. A. Fox, MBCHB; et al.
JAMA. 2005;293(23):2908-2917. doi:10.1001/jama.293.23.2908.
Commentary |  March 16, 2005
Regionalization of Care for Acute Coronary Syndromes:  More Evidence Is Needed
Saif S. Rathore, MPH; Andrew J. Epstein, PhD, MPP; Kevin G. M. Volpp, MD, PhD; et al.
JAMA. 2005;293(11):1383-1387. doi:10.1001/jama.293.11.1383.
Clinical Review |  January 19, 2005 FREE
A Simplified Approach to the Management of Non–ST-Segment Elevation Acute Coronary Syndromes
Ty J. Gluckman, MD; Molly Sachdev, MD, MPH; Steven P. Schulman, MD; et al.
JAMA. 2005;293(3):349-357. doi:10.1001/jama.293.3.349.
INCLUDES: CME
Original Contribution |  November 03, 2004 FREE
Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes:  Results From the CRUSADE Quality Improvement Initiative
Deepak L. Bhatt, MD; Matthew T. Roe, MD, MHS; Eric D. Peterson, MD, MPH; et al.
JAMA. 2004;292(17):2096-2104. doi:10.1001/jama.292.17.2096.
Grand Rounds |  October 20, 2004
Antiplatelet Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes
Steven P. Schulman, MD
JAMA. 2004;292(15):1875-1882. doi:10.1001/jama.292.15.1875.
Original Contribution |  July 07, 2004 FREE
Safety and Efficacy of Enoxaparin vs Unfractionated Heparin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Who Receive Tirofiban and Aspirin:  A Randomized Controlled Trial
Michael A. Blazing, MD; James A. de Lemos, MD; Harvey D. White, MD; et al.
JAMA. 2004;292(1):55-64. doi:10.1001/jama.292.1.55.
Review |  July 07, 2004 FREE
Efficacy and Bleeding Complications Among Patients Randomized to Enoxaparin or Unfractionated Heparin for Antithrombin Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes:  A Systematic Overview
John L. Petersen, MD; Kenneth W. Mahaffey, MD; Vic Hasselblad, PhD; et al.
JAMA. 2004;292(1):89-96. doi:10.1001/jama.292.1.89.
Original Contribution |  June 09, 2004 FREE
A Validated Prediction Model for All Forms of Acute Coronary Syndrome:  Estimating the Risk of 6-Month Postdischarge Death in an International Registry
Kim A. Eagle, MD; Michael J. Lim, MD; Omar H. Dabbous, MD, MPH; et al.
JAMA. 2004;291(22):2727-2733. doi:10.1001/jama.291.22.2727.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Research Letters  |  May 13, 2013
Serotonin Reuptake Inhibitor Use, Depression, and Long-Term Outcomes After an Acute Coronary Syndrome: A Prospective Cohort Study
Nina Rieckmann, PhD; Ian M. Kronish, MD, MPH; Peter A. Shapiro, MD; et al.
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
New Oral Anticoagulants in Acute Coronary Syndromes: What Does a Meta-analysis Tell Us?
Joey S. W. Kwong, PhD; Cheuk-Man Yu, MD
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
New Oral Anticoagulants in Acute Coronary Syndromes: What Does a Meta-analysis Tell Us?—Reply
András Komócsi, MD, DSc; András Vorobcsuk, MD, PhD; Dániel Aradi, MD, PhD
JAMA Internal Medicine
Challenges in Clinical Electrocardiography  |  March 11, 2013
ST-Segment Elevation Followed by Progressive Widening of the QRS Complex
Daniel Czuriga, MD, PhD; Judit Barta, MD, PhD; Ildiko Rácz, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems